Statistics for A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Basedon Adeno-Associated Virus.
Total visits
| views | |
|---|---|
| A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Basedon Adeno-Associated Virus. | 13 |
Total visits per month
| views | |
|---|---|
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 2 |
| July 2026 | 2 |
| August 2026 | 0 |
File Visits
| views | |
|---|---|
| Vardas et al._A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant_2010.pdf | 129 |